Stolen Identities, Millions in Medicaid Losses | New Jersey | Medicaid Fraud

A New Jersey man has been sentenced to four years in federal prison for participating in a multistate prescription fraud ring that used stolen Medicaid beneficiary information to obtain medications from pharmacies across the Northeast.

According to the U.S. Department of Justice, the defendant worked with several co-conspirators between April 2023 and October 2024 to steal personally identifiable information belonging to Medicaid recipients. The group then used those identities to fraudulently acquire prescription medications from pharmacies in multiple states.

The stolen beneficiary information allowed members of the ring to present themselves as legitimate patients or otherwise obtain medications using coverage for which they were not eligible. The conspiracy ultimately caused nearly $4 million in losses to New York’s Medicaid program, along with additional losses totaling tens of thousands of dollars for affected pharmacies.

The defendant pleaded guilty to conspiracy to commit health care fraud and aggravated identity theft. In addition to serving 48 months in prison, he will be subject to post-release supervision and other penalties imposed by the court.

The case demonstrates how stolen identities can serve as the foundation for fraud schemes that extend well beyond a single transaction or jurisdiction. Once compromised, a beneficiary’s information may be used repeatedly across pharmacies, health care providers and state lines before the activity is identified.

Health care fraud involving prescription medications can also create consequences beyond financial losses. Inaccurate claims may become associated with a legitimate beneficiary’s health record, potentially complicating future treatment, coverage decisions or medication histories.

Detecting this type of activity requires more than confirming that a name and Medicaid identification number match. Agencies and pharmacies must be able to evaluate prescribing patterns, pharmacy activity, geographic inconsistencies and repeated use of beneficiary information across multiple transactions.

The investigation involved the FBI, the U.S. Department of Health and Human Services Office of Inspector General and state authorities. It underscores the value of collaboration and data sharing when fraud moves between providers, pharmacies and government programs.

Today’s Fraud of the Day is based on reporting from the U.S. Department of Justice regarding a multistate prescription fraud investigation and sentencing announced in July 2026.